US neurosurgical company specializing in MRI-guided robotically controlled laser ablation for brain tumors and drug-resistant epilepsy.
Monteris Medical is a private equity-backed neurosurgical company founded in Winnipeg, Canada in 1999, now headquartered in Minnetonka, Minnesota, USA. The company focuses exclusively on diseases of the brain and commercializes the NeuroBlate System, a minimally invasive robotically controlled laser thermal therapy device that uses MRI-guided laser light to ablate unwanted brain tissue. The NeuroBlate System is indicated for brain tumors, radiation necrosis, and drug-resistant epilepsy, offering an alternative to open neurosurgical resection.
The robotically controlled probe delivery system enables precise, real-time thermal monitoring under MRI imaging. Monteris relocated its US headquarters to the Minneapolis metropolitan area around 2012 and maintains a Canadian office in Winnipeg, Manitoba. In 2025 the company announced a strategic collaboration with Symphony Robotics to develop an AI-driven micro-robotic platform for laser ablation.
Primary type & automation activities this supplier delivers:
MRI-guided robotically controlled laser thermal therapy system for minimally invasive ablation of brain tumors and epileptic foci.
Contact Monteris Medical
WEBSITE
https://monteris.comPHONE
+1 866.799.7655HEADQUARTERS
United States
Company Facts
Founded
1999
Primary Role
Manufacturer
Company Size
-
Primary Region
North America
Annual Sales
-
Funding Stage
-
Funding Total
-